Skip to content

Michael Bowen

5 papers in the library · 101 citations · publishing 2011-2026

Papers

Sort Most recent Most cited

Goal Setting and Anchoring Effects on Meditation Using a Digital Platform: Large-Scale Digital Field Study.

Journal of Medical Internet Research April 9, 2026 Michael Bowen, Michael Beam

Background: Meditation has grown in popularity in recent years, but many people who try meditation often fail to establish a habit. Goal setting has been demonstrated to be an effective technique in behavior change in other health-related contexts but is understudied in the meditation context. Objective: This study had 2 objectives: (1) to assess the association between goal setting and the...

Evaluating Theory-Driven Messaging to Overcome the Barriers to Meditation: Large-Scale Digital Field Experiment.

JMIR Mental Health July 7, 2025 Michael Bowen, Michael Beam, Joakim Semb et al. 2 citations

The general public is largely aware of meditation, and there is compelling evidence the practice has health benefits. But many people who are aware of meditation have not tried it, and those who do often struggle to establish a regular practice. The barriers to meditation are generally understood and include a lack of knowledge, a lack of time, and unclear benefits. These barriers present an...

Mapping Mindfulness: Assessing the Stages of Meditation Habit Formation in the USA Using the Sussex Mindfulness Meditation (SuMMed) Model

Mindfulness May 1, 2025 Michael Bowen, Michael Beam

Abstract Objectives The objective of this research was to map the Sussex Mindfulness Meditation (SuMMed) model to US adults, thereby demonstrating its utility for future researchers. Additionally, the research explored engagement with meditation beyond what the model explicitly prescribes, including with apps. This served as a means to offer potential refinements to the model and deepen our...

Emerging medications and pharmacological treatment approaches for substance use disorders.

Pharmacology, Biochemistry, and Behavior March 1, 2025 Joel S Raymond, Alexander G Athanasopoulos, Connie J Badolato et al. 7 citations

Medications to treat substance use disorders (SUDs) remain suboptimal or, in the case of stimulants and cannabis, non-existent. Many factors have contributed to this paucity, including the biological complexity of addiction, regulatory challenges, and a historical lack of enthusiasm among pharmaceutical companies to commit resources to this disease space. Despite these headwinds, the recent...

Mephedrone (4‐methylmethcathinone, ‘meow’): acute behavioural effects and distribution of Fos expression in adolescent rats

Addiction Biology October 13, 2011 Craig P. Motbey, Glenn E. Hunt, Michael T. Bowen et al. 92 citations

Mephedrone (4-methylmethcathinone) is a novel recreational drug that has rapidly increased in popularity in recent years. Users report mephedrone as having the stimulant-like qualities of methamphetamine and cocaine, combined with the prosocial, entactogenic effects of 3,4-methylenedioxymethamphetamine (MDMA). Anecdotal and case study reports indicate that mephedrone may have the potential to...